Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis.

Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis.

Portal hypertension is a direct consequence of hepatic fibrosis, and several hepatic fibrosis markers have been evaluated as a noninvasive alternative to the detection of portal hypertension and esophageal varices. In the present study, we compared the diagnostic and prognostic values of the noninva...

Full description

Bibliographic Details
Main Authors:	Eun Ju Cho, Moon Young Kim, Jeong-Hoon Lee, Il Young Lee, Yoo Li Lim, Dae Hee Choi, Yoon Jun Kim, Jung-Hwan Yoon, Soon Koo Baik
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4511411?pdf=render

Similar Items

Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis.
by: Gaeun Kim, et al.
Published: (2017-01-01)

Impact of sarcopenia on prognostic value of cirrhosis: going beyond the hepatic venous pressure gradient and MELD score
by: Seong Hee Kang, et al.
Published: (2018-10-01)

Correlation and prognostic accuracy between noninvasive liver fibrosismarkers and portal pressure in cirrhosis: Role of ALBI score.
by: Yun-Cheng Hsieh, et al.
Published: (2018-01-01)

Transient elastography versus hepatic venous pressure gradient for diagnosing portal hypertension: a systematic review and meta-analysis
by: Gaeun Kim, et al.
Published: (2017-03-01)

Accuracy of noninvasive tests in the prediction of portal hypertensive gastropathy in Egyptian patients with cirrhosis
by: Ibrahim F Amer, et al.
Published: (2021-02-01)

Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis.
by: Le Wang, et al.
Published: (2017-01-01)

Prognostic indicators in primary biliary cirrhosis: significance of revised IAHG (International Autoimmune Hepatitis Group) score
by: Ho Eun Jung, et al.
Published: (2012-12-01)

Clinical outcomes of transjugular intrahepatic portosystemic shunt for portal hypertension: Korean multicenter real-practice data
by: Hyung Ki Kim, et al.
Published: (2014-03-01)

Forns index as a useful noninvasive predictor of esophageal varices in liver cirrhosis
by: Rizqi Arini Siregar, et al.
Published: (2016-12-01)

Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease
by: Young Seok Kim, et al.
Published: (2013-06-01)

Non-Invasive Diagnostic and Prognostic Evaluation of Liver Cirrhosis and Portal Hypertension
by: Annalisa Berzigotti, et al.
Published: (2011-01-01)

Prognostic Markers in Patients with Cirrhosis and Portal Hypertension Who Have Not Bled
by: Maria Poca, et al.
Published: (2011-01-01)

Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study
by: Ji Hyun Kim, et al.
Published: (2020-11-01)

Noninvasive Predictors of High-Risk Varices in Patients with Non-Cirrhotic Portal Hypertension
by: Morven E. Cunningham, et al.
Published: (2019-01-01)

Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis
by: Jung Wha Chung, et al.
Published: (2014-12-01)

Response-Related Factors of Bone Marrow-Derived Mesenchymal Stem Cells Transplantation in Patients with Alcoholic Cirrhosis
by: Haripriya Gupta, et al.
Published: (2019-06-01)

Noninvasive examinations of portal hypertension
by: LIN Shanshan
Published: (2019-01-01)

The cut-off value of transient elastography to the value of hepatic venous pressure gradient in alcoholic cirrhosis
by: Se Ri Ryu, et al.
Published: (2021-01-01)

Risk of Liver Cirrhosis and Hepatocellular Carcinoma after Fontan Operation: A Need for Surveillance
by: Jun Sik Yoon, et al.
Published: (2020-07-01)

Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension
by: Jae Hyun Kim, et al.
Published: (2014-12-01)

Relationship between the hepatic venous pressure gradient and first variceal hemorrhage in patients with cirrhosis: a multicenter retrospective study in Korea
by: Jin Nyoung Kim, et al.
Published: (2012-12-01)

Noninvasive markers for esophageal varices in children with cirrhosis
by: Parisa Rahmani, et al.
Published: (2021-01-01)

P-118 NONINVASIVE PARAMETERS OF PREDICTORS OF ESOPHAGEAL VARICES (EV) IN CHILDREN WITH INTRAHEPATIC PORTAL HYPERTENSION
by: Marina R. Adam, et al.
Published: (2021-09-01)

Urinary exosome microRNA signatures as a noninvasive prognostic biomarker for prostate cancer
by: Sun Shin, et al.
Published: (2021-06-01)

Ultrasonographic scoring system score versus liver stiffness measurement in prediction of cirrhosis
by: Kyoung Min Moon, et al.
Published: (2013-12-01)

The performance of prognostic models as predictors of mortality in patients with acute decompensation of cirrhosis
by: Leonardo Fayad, et al.
Published: (2015-01-01)

Advances and challenges in cirrhosis and portal hypertension
by: Annalisa Berzigotti
Published: (2017-11-01)

Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma
by: Soon Ha Kwon, et al.
Published: (2012-09-01)

Observing the quantum Cheshire cat effect with noninvasive weak measurement
by: Yosep Kim, et al.
Published: (2021-01-01)

Myocardial structural and functional changes in patients with liver cirrhosis awaiting liver transplantation: a comprehensive cardiovascular magnetic resonance and echocardiographic study
by: Hyue Mee Kim, et al.
Published: (2020-04-01)

Severe portal hypertension in cirrhosis: evaluation of perfusion parameters with contrast-enhanced ultrasonography.
by: Woo Kyoung Jeong, et al.
Published: (2015-01-01)

Noninvasive Imaging of Pericardium
by: Bae Young Lee
Published: (2020-03-01)

Hematological Indices in Portal Hypertension: Cirrhosis versus Noncirrhotic Portal Hypertension
by: Abdurrahman Sahin, et al.
Published: (2018-08-01)

Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis
by: Dae Hoe Gu, et al.
Published: (2018-09-01)

Soluble TNF-alpha-receptors I are prognostic markers in TIPS-treated patients with cirrhosis and portal hypertension.
by: Jonel Trebicka, et al.
Published: (2013-01-01)

Portal vein thrombosis in patients with cirrhosis: just a common finding or a predictor of poor outcome?
by: Omar D. Borjas-Almaguer, et al.
Published: (2016-11-01)

The refit model for end-stage liver disease-Na is not a better predictor of mortality than the refit model for end-stage liver disease in patients with cirrhosis and ascites
by: Jun Jae Kim, et al.
Published: (2014-03-01)

Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban
by: Hyeyoung Yang, et al.
Published: (2016-12-01)

Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal
by: Yun Jung Choi, et al.
Published: (2014-06-01)

Portal Thrombosis in Cirrhosis: Role of Thrombophilic Disorders
by: José Ignacio Fortea, et al.
Published: (2020-08-01)

Cannot write session to /tmp/vufind_sessions/sess_dnbq15jv5smv3m4ef6q8i1f2el